Obstetrics and gynecology
Obstetrics and maternal-fetal medicine, gynecologic oncology, reproduction and endocrinology, minimally invasive surgery and pelvic floor.
Published issues
- Monthly obstetrics and gynecology bulletin — November 12, 2026
This issue covers what was published, presented, or released between October 15 and November 12, 2026. It was a congress-driven period: ESMO in Madrid delivered three phase 3 trials in endometrial cancer (two of them…
🎧 ListenAudio newscast · 6:26 min - Obstetrics and gynecology bulletin — October 25, 2026
Coverage: October 13–25, 2026, following the latest regular issue dated October 12. Six publications with dates and findings checked against their sources.
🎧 ListenAudio newscast · 5:51 min - What's next in obstetrics and gynecology — October 22, 2026
This edition covers what is coming in obstetrics and gynecology between late October 2026 and March 2027: two phase 3 endometrial cancer trials in the ESMO 2026 presidential symposium, the European decision on a new…
🎧 ListenAudio newscast · 4:02 min - Monthly obstetrics and gynecology bulletin — October 12, 2026
This issue covers October 2 to 12, 2026, the eleven days since the previous issue (October 1). It is a short period and carries seven verified items; two come from outside North America and Western Europe (Dominican…
🎧 ListenAudio newscast · 6:12 min - Monthly obstetrics and gynecology bulletin — October 1, 2026
Period covered: September 1 to October 1, 2026. A thin month: 10 verified items, none of them a major new randomized trial. The most solid are a meta-analysis with consensus on GLP-1 receptor agonists in pregnancy and…
🎧 ListenAudio newscast · 6:23 min - Monthly obstetrics and gynecology bulletin — September 28, 2026
Period covered: August 29 to September 28, 2026. Note for the month: it was a thin month for large randomized trials in our specialty; the most solid material came from reference reviews, regulatory decisions and…
🎧 ListenAudio newscast · 5:57 min - Monthly obstetrics and gynecology bulletin — September 18, 2026
Period covered: August 18 to September 18, 2026. Ten verified items. A moderate-volume month: no new drug regulatory approvals or new phase 3 trials in gynecologic oncology; the strongest material is in contraception,…
🎧 ListenAudio newscast · 6:02 min